Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Colonic Neoplasms: HELP
Jean Francois Emile
Based on 5 articles published since 2009
(Why 5 articles?)
||||
Expertise Level
The expertise of Jean Francois Emile ranks in the
  • Top 1.6%
  • ... of 85,108 published authors worldwide on Colonic Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 5 articles on the topic.
Graphical view (beta)
Aliases Emile, Jean-François   ·   Emile, Jean Francois
Work Locations
Details
Most likely:    Universite de Versailles Saint-Quentin-en-Yvelines      
2019
  • Digestive Oncology, University Hospital of Nantes, Nantes, France; University of Nantes, Nantes, France. Electronic address: · Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France; Sorbonne Universités, UMPC Paris 06, Paris, France. · Biometrics, ICO Cancer Center, Nantes, France; CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, France. · Department of Medical Oncology, ICO Cancer Center, Nantes, France. · Centre Hospitalier Privé St Grégoire, Saint Grégoire, France. · Institut Sainte Catherine, Avignon, France. · Digestive Oncology, University Hospital of Nantes, Nantes, France. · Hôpital Privé Jean Mermoz, Lyon, France. · Division of Oncology, Allan Blair Cancer Centre, Regina, Saskatchewan, Canada. · Service Hépatogastroentérologie et Cancérologie Digestive, CHU Robert Debré, Reims, France. · Centre Hospitalier de Saintonges, Saintes, France. · Jewish General Hospital-McGill University, Montreal, Canada. · Centre Hospitalier de Cholet, Cholet, France. · CH Chartres Louis Pasteur-Coudray, Chartres, France. · Pathology Department, Ambroise Paré Hospital, Boulogne-Billancourt, France. · UNICANCER, Paris, France. · Division of Medical Oncology, British Columbia Cancer Agency; University of British Columbia, Vancouver, British Columbia, Canada. · Sorbonne Paris Cité, Paris Decartes University; Hôpital Européen Georges-Pompidou, Paris, France. · Pubmed 30415988
2017
  • Affiliations of authors: Department of Gastroenterology and GI Oncology, Université Paris Descartes, Hopital Européen Georges Pompidou, Paris, France (JTai) · Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France (KLM) · Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN (QS, DJS) · Department of Pathology, Centre Jean Perrin, EA ERTICa, Université d'Auvergne, Clermont-Ferrand, France (FPL) · Centre Hospitalier Universitaire Robert Debré, Reims, France (OB) · Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain (JTab) · Spanish Gastrointestinal Tumors TTD Group, Universitat Autònoma de Barcelona, Barcelona, Spain (JTab) · Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy (EM) · Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG) · First Medical Department, University Hospital Carl Gustav Carus, Dresden, Germany (GF) · Department of Gastroenterology, Hôpital Universitaire Erasme, Brussels, Belgium (JLVL) · Department of Oncology, Mayo Clinic and Mayo Cancer Center, Rochester, MN (SRA, FAS) · Pathology Department, Ambroise Paré Hospital, Boulogne, France (JFE) · Université Paris Descartes, Sorbonne Paris Cité, France (PLP) · Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France (PLP) · INSERM UMR-S1147, Paris, France (PLP). · Pubmed 28040692
  • EA4340, Versailles University, Paris-Saclay University, Boulogne, France; Assistance Publique Hôpitaux de Paris, Hopital Ambroise Paré, Boulogne, France. Electronic address: · EA4340, Versailles University, Paris-Saclay University, Boulogne, France; Assistance Publique Hôpitaux de Paris, Hopital Ambroise Paré, Boulogne, France. · Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France. · Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France; Department of Hepato-Gastroenterology, Dijon University Hospital, Dijon, France; UMR 866, INSERM, Dijon, France. · Vall D'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Section of Internal Medicine, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. · Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany. · Department of Gastroenterology, Erasme Hospital University, Brussels, Belgium. · Department of Pathology, Hospital of La Roche sur Yon, La Roche sur Yon, France. · Department of Pathology, University Hospital of Reims, Reims, France. · EA4340, Versailles University, Paris-Saclay University, Boulogne, France. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Gastroenterology, Centre Rene Gauducheau, Saint-Herblain, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France; INSERM UMR-S1147 Centre Universitaire des Saints Pères, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Paris Descartes University, Paris Sorbonne cité, Department of Digestive Oncology, HEGP, Paris, France. · Pubmed 28651158
2014
  • Department of Gastroenterology and Digestive Oncology, Paris Descartes University, Hôpital Européen Georges Pompidou, Paris, France. Electronic address: · Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain. · Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. · Francophone Federation of Digestive Oncology, Cedex Dijon, France; University of Lyon, Lyon, France; Laboratoire de Biométrie et Biologie Evolutive, Villeurbanne, France; Hospices Civils de Lyon, Service de Biostatistique, Lyon, France. · 1st Medical Department, University Hospital Carl Gustav Carus, Dresden, Germany. · Department of Gastroenterology, Hôpital Universitaire Erasme, Brussels, Belgium. · Department of Internal Medicine IV, Klinikum Kreuzschwestern Wels, Austria. · UCL Cancer Institute, University College London, London, UK. · Department of Oncology, Rigshospitalet, København, Denmark. · Université Paris Descartes, Sorbonne Paris Cité, France; Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France; UMR-S775, INSERM, Centre Universitaire des Saints Pères, Paris, France. · Statistics Department, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgium. · Department of Gastroenterology and Digestive Oncology, Paris Descartes University, Hôpital Européen Georges Pompidou, Paris, France. · Catalan Institute of Oncology (IDIBELL), Barcelona, Spain. · Hepato-Gastroenterology Department Dijon University Hospital and INSERM U 866, France. · EA4340 and Pathology Department, Versailles University and Ambroise Paré Hospital APHP, Boulogne, France. · Université Paris Descartes Sorbonne Paris Cité France; UMR-S775, INSERM, Bases Moléculaires de la Réponse aux Xénobiotiques, Paris France; Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France. · Pubmed 24928083
Probable:    Universite Paris-Saclay      
2017
  • EA4340, Versailles University, Paris-Saclay University, Boulogne, France; Assistance Publique Hôpitaux de Paris, Hopital Ambroise Paré, Boulogne, France. Electronic address: · EA4340, Versailles University, Paris-Saclay University, Boulogne, France; Assistance Publique Hôpitaux de Paris, Hopital Ambroise Paré, Boulogne, France. · Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France. · Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France; Department of Hepato-Gastroenterology, Dijon University Hospital, Dijon, France; UMR 866, INSERM, Dijon, France. · Vall D'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Section of Internal Medicine, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. · Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany. · Department of Gastroenterology, Erasme Hospital University, Brussels, Belgium. · Department of Pathology, Hospital of La Roche sur Yon, La Roche sur Yon, France. · Department of Pathology, University Hospital of Reims, Reims, France. · EA4340, Versailles University, Paris-Saclay University, Boulogne, France. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Gastroenterology, Centre Rene Gauducheau, Saint-Herblain, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France; INSERM UMR-S1147 Centre Universitaire des Saints Pères, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Paris Descartes University, Paris Sorbonne cité, Department of Digestive Oncology, HEGP, Paris, France. · Pubmed 28651158
Possible:    Georges Pompidou European Hospital      
2011
  • Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, Paris, France. · Pubmed 21998335
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Jean Francois Emile in 2009-2019 about Colonic Neoplasms:

  • Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer-A UNICANCER GI-PRODIGE Trial. 2019
  • Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer. 2017
  • Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX. 2017
  • Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial. 2014
  • Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy. 2011
Show List of Full Article Records
Google Searches

Learn more about Jean Francois Emile using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universite de Versailles Saint-Quentin-en-Yvelines
Universite Paris-Saclay
Georges Pompidou European Hospital
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universite de Versailles Saint-Quentin-en-Yvelines
2019
  • Digestive Oncology, University Hospital of Nantes, Nantes, France; University of Nantes, Nantes, France. Electronic address: · Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France; Sorbonne Universités, UMPC Paris 06, Paris, France. · Biometrics, ICO Cancer Center, Nantes, France; CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, France. · Department of Medical Oncology, ICO Cancer Center, Nantes, France. · Centre Hospitalier Privé St Grégoire, Saint Grégoire, France. · Institut Sainte Catherine, Avignon, France. · Digestive Oncology, University Hospital of Nantes, Nantes, France. · Hôpital Privé Jean Mermoz, Lyon, France. · Division of Oncology, Allan Blair Cancer Centre, Regina, Saskatchewan, Canada. · Service Hépatogastroentérologie et Cancérologie Digestive, CHU Robert Debré, Reims, France. · Centre Hospitalier de Saintonges, Saintes, France. · Jewish General Hospital-McGill University, Montreal, Canada. · Centre Hospitalier de Cholet, Cholet, France. · CH Chartres Louis Pasteur-Coudray, Chartres, France. · Pathology Department, Ambroise Paré Hospital, Boulogne-Billancourt, France. · UNICANCER, Paris, France. · Division of Medical Oncology, British Columbia Cancer Agency; University of British Columbia, Vancouver, British Columbia, Canada. · Sorbonne Paris Cité, Paris Decartes University; Hôpital Européen Georges-Pompidou, Paris, France. · Pubmed 30415988
2017
  • Affiliations of authors: Department of Gastroenterology and GI Oncology, Université Paris Descartes, Hopital Européen Georges Pompidou, Paris, France (JTai) · Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France (KLM) · Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN (QS, DJS) · Department of Pathology, Centre Jean Perrin, EA ERTICa, Université d'Auvergne, Clermont-Ferrand, France (FPL) · Centre Hospitalier Universitaire Robert Debré, Reims, France (OB) · Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain (JTab) · Spanish Gastrointestinal Tumors TTD Group, Universitat Autònoma de Barcelona, Barcelona, Spain (JTab) · Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy (EM) · Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG) · First Medical Department, University Hospital Carl Gustav Carus, Dresden, Germany (GF) · Department of Gastroenterology, Hôpital Universitaire Erasme, Brussels, Belgium (JLVL) · Department of Oncology, Mayo Clinic and Mayo Cancer Center, Rochester, MN (SRA, FAS) · Pathology Department, Ambroise Paré Hospital, Boulogne, France (JFE) · Université Paris Descartes, Sorbonne Paris Cité, France (PLP) · Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France (PLP) · INSERM UMR-S1147, Paris, France (PLP). · Pubmed 28040692
  • EA4340, Versailles University, Paris-Saclay University, Boulogne, France; Assistance Publique Hôpitaux de Paris, Hopital Ambroise Paré, Boulogne, France. Electronic address: · EA4340, Versailles University, Paris-Saclay University, Boulogne, France; Assistance Publique Hôpitaux de Paris, Hopital Ambroise Paré, Boulogne, France. · Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France. · Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France; Department of Hepato-Gastroenterology, Dijon University Hospital, Dijon, France; UMR 866, INSERM, Dijon, France. · Vall D'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Section of Internal Medicine, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. · Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany. · Department of Gastroenterology, Erasme Hospital University, Brussels, Belgium. · Department of Pathology, Hospital of La Roche sur Yon, La Roche sur Yon, France. · Department of Pathology, University Hospital of Reims, Reims, France. · EA4340, Versailles University, Paris-Saclay University, Boulogne, France. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Gastroenterology, Centre Rene Gauducheau, Saint-Herblain, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France; INSERM UMR-S1147 Centre Universitaire des Saints Pères, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Paris Descartes University, Paris Sorbonne cité, Department of Digestive Oncology, HEGP, Paris, France. · Pubmed 28651158
2014
  • Department of Gastroenterology and Digestive Oncology, Paris Descartes University, Hôpital Européen Georges Pompidou, Paris, France. Electronic address: · Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain. · Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. · Francophone Federation of Digestive Oncology, Cedex Dijon, France; University of Lyon, Lyon, France; Laboratoire de Biométrie et Biologie Evolutive, Villeurbanne, France; Hospices Civils de Lyon, Service de Biostatistique, Lyon, France. · 1st Medical Department, University Hospital Carl Gustav Carus, Dresden, Germany. · Department of Gastroenterology, Hôpital Universitaire Erasme, Brussels, Belgium. · Department of Internal Medicine IV, Klinikum Kreuzschwestern Wels, Austria. · UCL Cancer Institute, University College London, London, UK. · Department of Oncology, Rigshospitalet, København, Denmark. · Université Paris Descartes, Sorbonne Paris Cité, France; Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France; UMR-S775, INSERM, Centre Universitaire des Saints Pères, Paris, France. · Statistics Department, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgium. · Department of Gastroenterology and Digestive Oncology, Paris Descartes University, Hôpital Européen Georges Pompidou, Paris, France. · Catalan Institute of Oncology (IDIBELL), Barcelona, Spain. · Hepato-Gastroenterology Department Dijon University Hospital and INSERM U 866, France. · EA4340 and Pathology Department, Versailles University and Ambroise Paré Hospital APHP, Boulogne, France. · Université Paris Descartes Sorbonne Paris Cité France; UMR-S775, INSERM, Bases Moléculaires de la Réponse aux Xénobiotiques, Paris France; Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France. · Pubmed 24928083
Universite Paris-Saclay
2017
  • EA4340, Versailles University, Paris-Saclay University, Boulogne, France; Assistance Publique Hôpitaux de Paris, Hopital Ambroise Paré, Boulogne, France. Electronic address: · EA4340, Versailles University, Paris-Saclay University, Boulogne, France; Assistance Publique Hôpitaux de Paris, Hopital Ambroise Paré, Boulogne, France. · Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France. · Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France; Department of Hepato-Gastroenterology, Dijon University Hospital, Dijon, France; UMR 866, INSERM, Dijon, France. · Vall D'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Section of Internal Medicine, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. · Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany. · Department of Gastroenterology, Erasme Hospital University, Brussels, Belgium. · Department of Pathology, Hospital of La Roche sur Yon, La Roche sur Yon, France. · Department of Pathology, University Hospital of Reims, Reims, France. · EA4340, Versailles University, Paris-Saclay University, Boulogne, France. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Gastroenterology, Centre Rene Gauducheau, Saint-Herblain, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France; INSERM UMR-S1147 Centre Universitaire des Saints Pères, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Paris Descartes University, Paris Sorbonne cité, Department of Digestive Oncology, HEGP, Paris, France. · Pubmed 28651158
Georges Pompidou European Hospital
2011
  • Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, Paris, France. · Pubmed 21998335
Yearly article counts 10200100100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.